Blackstone Life Sciences

Blackstone Life Sciences, shortened to BXLS, is the life sciences investment business within Blackstone. It funds and partners with pharmaceutical, biotechnology and medical technology companies, and draws on Blackstone's global network and infrastructure.

The team pairs capital with clinical, commercial and operational experience. It selects products and companies it considers promising and stays closely involved once it has committed funds.

Services

• Product and company funding: finances medicines and healthcare technologies that address unmet medical needs.
• Late-stage development investment: favours candidates in late-stage development, aiming to reach many patients at lower clinical risk.
• Hands-on partnership: applies clinical development and commercial know-how directly to the companies it backs.
• Life-cycle coverage: holds stakes at different points in a company or product's development, spanning several therapeutic areas.

Who it serves

Pharmaceutical, biotech and medical technology companies, and investors looking for exposure to the life sciences.

Key facts

• Part of: Blackstone
• Team: includes members holding medical or doctoral degrees
• Focus: several therapeutic areas, with an emphasis on late-stage development